PT124.S4.P3.Q15 > Analytics

Hide analysis

The passages discuss relationships between business interests and university research.

███████ █

Problem · Trend of treating university research findings as commodities

Threatens the tradition and role of research as a public good.

███ █████████ ███ ███ █████ ███ █████████████ █████████████ █████ ███████ ██ ███████████ ████████ ██████ ██ ███ ███████████ ███████ ███ ████████ ██ █████████ ██████████████ ███ ██████ ███████ ███ ██████ █████████ █████████ ████████ ███ ███ ██████ ██ ███ ███████████ ███ ██████████ ██ ███ ██████ ████ █████ ████████████ █████████ ███ █████ ████████ ██████████ ███ ██████ ██ ████████████ ████████████████ ████ ████ ██ ████ ████ ██████████ ███ ██████████ ███████████ ███████ ███ █████ ██ █████████ ██████ ██ ██████ ███ ███████████ ██ █████████ ███████████ ███████████

Details of problem · Universities are suited to experimentation, but businesses are not

Introduction of market values into universities threatens the universities' traditional role.

████████ █████ █████████████ ███████ ████ ██████ ████████ ███ █████████ ██ ███ ████████████ █████ ████ ███ ███ ████████ ███ ████ ███ █████████ ██████ █████████ ██████ ██ ███████ ██ ██ █████ ████████████ ███ ██████ ██ ██████████ ██████████████ ███ ████████ ███ ████ ███████████ ██ █ █████████ ██ ███ ████ ███████ ██ ████████ ███████ ███ ███████████ ████ █████ ██ ███ ███ ███ █████████ ████████ ██ ███ █████ ███ ██████████

Additional details of problem · Businesses can hide their own research

For example, growth of industrial biotechnology has led to less sharing of research in the field.

Author's concern · Doesn't like the trend of treating research as commodities

███████ █

Traditional perspective · Scientific research was a public good

Since most benefits of research came from government support of universities, no individual had the right to restrict access to those benefits.

██████ ████████ ███ ████████ ████ ██ ███████ ██ ███ ██████ ████████████ ████████ █████ ████ ████ ███ ██████████ ████ ██ █ ██████ ████ ██ █████ ███████████ ████ █ ██████ ██████████ ███ ████████ ██ ██████████ ███ ███████████ ████ █████ ████████ ███ ███████████ █████ ███ ████████ ██████████ ██ █████ ███ ██████ ███ █████████████ ████████ ███ ██████ ██████████ ███████████████ ██ ███████ █████████ █████████████ ██ ████ ████████ █████████ ██ █████ ██████ ██ █████████████ ███████████████ ████ ██ ██████████ ████████ ███ ██ ███ ██████████ ██████████ ███████████████████ ████████

New perspective · Research is becoming market commodity subject to claims of intellectual property

Example: biotechnology industry uses research to make profits off of products. They can claim that the underlying scientific knowledge is their intellectual property.

███████████ ███ ███████████ ███████ █ ██████████ ███████████ ██████ █████ ███ ██ █████████ ███ █ █████████ ███████████ ██████ ██████ ███████ ███ ██████ ██ ██████████ ███████ ██ ██████ ██████████ ██████ ████████ ███ █████ ████ █████ ██████████ ███████████ ███ ██ ██████ ████ ████████ ███ ███ █████ ███████ █████████ ████ ████ ██████████████ ████ ███ ██ █ ████████ ██ ████ ███ █████ ███████████ ███████ █████████ ███ █████████ ███ ███ █████ ███████████ ███████ ████ ██████ ███ ██████ ███ ██ █████████

Distinction between discovery and invention · Is blurring

Discoveries can't be patented, while inventions can be. But these distinctions are blurring both legally and morally.

Industries' argument · Entitled to seek return on investment in research

If business has supported research in its own labs or in universities, it shoudl get to charge others for using the research or keep the research for its own use.

Passage Style

15.

Which one of the following ██ █████████ ██ ███████ █ ███ ███ ██ ███████ ██

Question Type

Stated

We’re looking for an answer that’s mentioned in Passage B, but not in Passage A. If you’re using the Split Approach, you’ll start be eliminating answers that are mentioned in Passage A. Then you’ll come back to eliminate answers that are not mentioned in Passage B.

the blurring of ███ █████ ███████████ ███████ █████████ ███ █████████

This is discussed in P3 of Passage B. But Passage A doesn’t discuss this.

89%

the general effects ██ ███ ██████ ██ ███ ████████ ██ ██████████ █████████

Discussed in Passage A. (It’s arguably something brought up in Passage B, but this doesn’t matter because we’ve already eliminated it based on Passage A.)

the role of ██████████ ████████ ██ █████████ ██████ █████

Discussed in Passage A. (It’s brought up in Passage B, but this doesn’t matter because we’ve already eliminated it based on Passage A.)

new pharmaceuticals that ██████ ████ ██████████ ████████

Discussed in Passage A. (It’s brought up in Passage B, but this doesn’t matter because we’ve already eliminated it based on Passage A.)

industry's practice of ███████████ ██████ ██ ████████ ████████

Discussed in Passage A. (It’s brought up in Passage B, but this doesn’t matter because we’ve already eliminated it based on Passage A.)

Answer five questions and we'll estimate your score.

It takes about five minutes.

Take the free diagnostic

More free LSAT prep: Sample LSAT questions Full-length diagnostic & practice test All free LSAT resources

PrepTest 124 - Section 4 - Passage 3 - Question 15

Answer five questions and we'll estimate your score.

Difficulty

Analysis

Answer Popularity

Question history

Confirm action

PrepTest 124 - Section 4 - Passage 3 - Question 15

Answer five questions and we'll estimate your score.

Difficulty

Analysis

Answer Popularity

Question history

Want to know why the right answer is right?